ENVOL

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

Delandistrogene moxeparvovecOngoingActive not recruitingPhase 2Open NCT06128564 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

ENVOL · Trial Tracker · ComplyRx